Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Magini

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Hepatology|December 1, 2016
Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCCAndrea Notarpaolo, Richard Layese, Paolo Magistri, et al.
Gastroenterology|December 11, 2020
Protective Role of Tacrolimus, Deleterious Role of Age and Comorbidities in Liver Transplant Recipients With Covid-19: Results From the ELITA/ELTR Multi-center European StudyLuca S Belli, Constantino Fondevila, Paolo A Cortesi, et al.
Recenti Progressi in Medicina|May 22, 2015
[Therapeutic decisions and treatment with sorafenib in hepatocellular carcinoma: final analysis of GIDEON study in Italy]Salvatore D'Angelo, Domenico Germano, Teresa Zolfino, et al.
Journal of Hepatology|February 5, 2023
Utilization of livers donated after circulatory death for transplantation - An international comparisonJanina Eden, Richard Sousa Da Silva, Miriam Cortes-Cerisuelo, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 27, 2026
Preformed donor-specific antibodies are associated with acute rejection and biliary complications after liver transplantation: A Swiss Transplant Cohort Study analysisJulien Vionnet, Sylvie Ferrari-Lacraz, Linard David Hoessly, et al.
Swiss Medical Weekly|October 25, 2021
Management of transthyretin amyloidosisAdalgisa Condoluci, Marie Théaudin, Rahel Schwotzer, et al.
Gut|July 20, 2021
COVID-19 in liver transplant candidates: pretransplant and post-transplant outcomes - an ELITA/ELTR multicentre cohort studyLuca Saverio Belli, Christophe Duvoux, Paolo Angelo Cortesi, et al.
Journal of Hepatology|January 23, 2023
Alternative forms of portal vein revascularization in liver transplant recipients with complex portal vein thrombosisYiliam Fundora, Amelia J Hessheimer, Luca Del Prete, et al.
Hepatology (Baltimore, Md.)|February 15, 2024
Recent outcomes of liver transplantation for Budd-Chiari syndrome: A study of the European Liver Transplant Registry (ELTR) and affiliated centersEdo Dongelmans, Nicole Erler, Rene Adam, et al.
Journal of Hepatology|May 31, 2024
Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantationAldo J Montano-Loza, Ellina Lytvyak, Gideon Hirschfield, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Hepatology|December 1, 2016
Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCCAndrea Notarpaolo, Richard Layese, Paolo Magistri, et al.
Gastroenterology|December 11, 2020
Protective Role of Tacrolimus, Deleterious Role of Age and Comorbidities in Liver Transplant Recipients With Covid-19: Results From the ELITA/ELTR Multi-center European StudyLuca S Belli, Constantino Fondevila, Paolo A Cortesi, et al.
Recenti Progressi in Medicina|May 22, 2015
[Therapeutic decisions and treatment with sorafenib in hepatocellular carcinoma: final analysis of GIDEON study in Italy]Salvatore D'Angelo, Domenico Germano, Teresa Zolfino, et al.
Journal of Hepatology|February 5, 2023
Utilization of livers donated after circulatory death for transplantation - An international comparisonJanina Eden, Richard Sousa Da Silva, Miriam Cortes-Cerisuelo, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 27, 2026
Preformed donor-specific antibodies are associated with acute rejection and biliary complications after liver transplantation: A Swiss Transplant Cohort Study analysisJulien Vionnet, Sylvie Ferrari-Lacraz, Linard David Hoessly, et al.
Swiss Medical Weekly|October 25, 2021
Management of transthyretin amyloidosisAdalgisa Condoluci, Marie Théaudin, Rahel Schwotzer, et al.
Gut|July 20, 2021
COVID-19 in liver transplant candidates: pretransplant and post-transplant outcomes - an ELITA/ELTR multicentre cohort studyLuca Saverio Belli, Christophe Duvoux, Paolo Angelo Cortesi, et al.
Journal of Hepatology|January 23, 2023
Alternative forms of portal vein revascularization in liver transplant recipients with complex portal vein thrombosisYiliam Fundora, Amelia J Hessheimer, Luca Del Prete, et al.
Hepatology (Baltimore, Md.)|February 15, 2024
Recent outcomes of liver transplantation for Budd-Chiari syndrome: A study of the European Liver Transplant Registry (ELTR) and affiliated centersEdo Dongelmans, Nicole Erler, Rene Adam, et al.
Journal of Hepatology|May 31, 2024
Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantationAldo J Montano-Loza, Ellina Lytvyak, Gideon Hirschfield, et al.
Pageof 3